Latest Regentis Biomaterials News & Updates

See the latest news and media coverage for Regentis Biomaterials. We track all announcements, press releases, and industry mentions in real time, all in one place.

Regentis Biomaterials

Hydrogel implant developer for tissue repair

regentis.co.il

Headquarters: Herzliya, Israel
Company type: Public company
Number of employees: 10–50

Last updated Today

Latest news about Regentis Biomaterials

In short: Regentis Biomaterials advanced its GelrinC platform through clinical expansion, manufacturing improvements, and European commercialization efforts.

Company announcements

June 4 Regentis Biomaterials

Regentis Biomaterials discusses potential of GelrinC platform.

GelrinC could become the first widely adopted off-the-shelf regenerative cartilage repair platform.

June 4 Regentis Biomaterials

Regentis Biomaterials advances GelrinC toward commercialization

It details pivotal FDA study enrollment, CE Mark status, and collaboration with Humanitas, along with manufacturing scale-up.

May 26 Regentis Biomaterials

Regentis Biomaterials expands its Phase III GelrinC clinical site network

It is adding several leading orthopedic centers across the United States.

May 18 Regentis Biomaterials

Regentis Biomaterials develops and patents new manufacturing process

The solvent-free process increases GelrinC production yield by 400%.

Media coverage

Today The Desert Sun

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

HERZLIYA, IL / ACCESS Newswire / January 20, 2026 / Regentis Biomaterials Ltd., ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on...

June 15 The Globe and Mail

Regentis Biomaterials Appoints Chairman Ehud Geller as CEO After Hazum Resignation

Detailed price information for Regentis Biomaterials Ltd (RGNT-A) from The Globe and Mail including charting and trades.

June 15 Yahoo Finance

Why Did RGNT Stock Surge More Than 850% Today?

Regentis Biomaterials filed a notice to withdraw its Form F-1 registration statement, indicating that it did not wish to proceed with a proposed public...

March 17 Morningstar

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Proprietary process is already patented in several countries and is pending in the U.S. HERZLIYA, IL / ACCESS Newswire / March 17, 2026 / Regentis...

Never miss news about Regentis Biomaterials

Track Regentis Biomaterials and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.